Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration Agreement to Evaluate the Combination of ATI-2173 and Vebicorvir in Patients with Chronic Hepatitis B Virus Infection
/PRNewswire/ -- Antios Therapeutics, Inc. and Assembly Biosciences, Inc. (Nasdaq: ASMB) today announced that the companies have entered into a clinical...
John Mchutchison Gregory Mayes Assembly Biosciences Assembly Biosciences Inc Assembly Bio Lead World Health Organization
Source: prnewswire.com